Beatrice W T Yin

Title: Beatrice W T Yin: Innovator in Ovarian Cancer Detection

Introduction

Beatrice W T Yin is a notable inventor based in Forest Hills, NY (US). He has made significant contributions to the field of cancer research, particularly in the detection and treatment of ovarian cancer. His innovative work has led to the development of a patented method that holds promise for improving cancer diagnostics.

Latest Patents

Beatrice W T Yin holds a patent for a nucleic acid sequence encoding the ovarian antigen CA125 and its various uses. This invention provides an isolated nucleic acid molecule that comprises sequences encoding the CA125 protein or a portion thereof. The patent outlines methods to detect ovarian cancer in subjects, diagnose cancers that express CA125, and produce CA125 protein. Additionally, it includes methods for silencing CA125 protein production and treating or preventing cancer using a vaccine comprising CA125 nucleic acid or protein. He has 1 patent to his name.

Career Highlights

Beatrice W T Yin is affiliated with the Sloan-Kettering Institute for Cancer Research, where he has been involved in groundbreaking research. His work has contributed to advancements in understanding ovarian cancer and developing diagnostic tools that can potentially save lives.

Collaborations

He has collaborated with Kenneth O Lloyd, further enhancing the research efforts in the field of cancer detection and treatment.

Conclusion

Beatrice W T Yin's innovative contributions to ovarian cancer research exemplify the impact of dedicated inventors in the medical field. His patented methods offer hope for improved cancer diagnostics and treatment options.